This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
ICH Q6B Test Procedures And Acceptance Criteria For Biophysical Characterization
Talk to Our Scientists
ICH Q6B is a guideline developed by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). It focuses on the specification of test procedures and acceptance criteria for biotechnological/biological products. Accepted by FDA, EMeA, and Japanese regulatory agencies, this guideline details standards for biotechnological/biological products, including composition determination, physical properties, and structure of the therapeutic protein.
| ICH Q6B Compliance Criteria | |
|---|---|
| Structural Characterization and Confirmation: |
|
| Physicochemical Properties: |
|
| Impurities: |
|
Testing Procedures
CovalX provides comprehensive solutions for characterizing products in alignment with the ICH Q6B quality guidelines required for IND submission. Explore our offerings:
| Technique | |
|---|---|
| Application | |
| Hydrogen–Deuterium Exchange MS (HDX–MS | Epitope mapping / Conformational Analysis |
| Cross–linking MS (XL–MS) | Epitope mapping; provides both epitope and paratope information |
| Immunoprecipitation–MS (IP–MS) | Protein ID; identify protein–protein interactions within cells |
| Peptide Mass Fingerprinting (PMF) | Verifying known protein sequence |
| Post Translational Modifications (PTMs) | Identification of post translational modifications on the protein structure |
| Disulfide Bridge Mapping | Identification of disulfide bonds present within a protein sample |
| Free Sulfhydryl Analysis | Identification of free sulfhydryls present within a protein sample |
| Glycosylation sites | Identification of glycosylation sites within a protein sample |
| Size exclusion chromatography (SEC) | Purity analysis; separates based on size |
| Reverse–phase HPLC | Purity analysis; separates based on polarity |
| Circular Dichroism (CD) | Determination of protein secondary structure features |
| Multi–Angle Light Scattering (SEC–MALS) | Identification of protein aggregates |
| Analytical Ultracentrifugation (AUC) | Identification of protein aggregates |
| Fourier Transform Infrared Spectroscopy (FTIR) | Determination of secondary structure in protein |
| Differential Scanning Calorimetry (DSC) | Thermal stability of the protein |
| Dynamic Light Scattering (DLS) | Identification of protein aggregates |
| Cation–Exchange Chromatography (CEX–HPLC) | Purity analysis; separates based on charge |
| Capillary Electrophoresis (CE–SDS) | Purity analysis; separates based on size/charge |
| Capillary Isoelectric Focusing (cIEF) | Purity analysis; separates based on isoelectric point |
| Surface Plasmon Resonance Analysis (SPR) | Binding affinity analysis |
| Monosaccharide Composition | Quantification of potential harmful monosaccharides |
| Oligosaccharide Linkage Patterns | Identification of glycan structure |